Thumbnail Image
Publication

Severe oral mucositis (SOM) mitigation by genetically modified lactococcus lactis bacteria (LLB) producing human trefoil factor 1 (hTFF1; AG013) in patients being treated with concomitant chemoradiation (CRT) for oral and oropharyngeal cancers (OCOPC)

Singh, S
; 
Nuyts, S
; 
Doline, R
; 
Satti, S
; 
Schwartz, M
; 
Thatcher, S
; 
Chen, Y
; 
Katz, S
; 
Garg, M
; 
Wagemans, J
... show 9 more
Citations
Altmetric:
Abstract
Authors
Singh, S
Nuyts, S
Doline, R
Satti, S
Schwartz, M
Thatcher, S
Chen, Y
Katz, S
Garg, M
Wagemans, J
Specenier, P
Wittekindt, C
Lee, Lip W
Reifler, J
Sonis, S
Emanuel, M
Cilli, F
Joslyn, A
Wade, J
Affiliation
Radiation Oncology, Multicare Regional Cancer Center, Tacoma, WA
Description
Date
2019
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL. Conference abstract
Adobe PDF, 94.41 KB
Keywords
Type
Meetings and Proceedings
Citation
Singh S, Nuyts S, Doline R, Satti S, Schwartz M, Thatcher S, et al. 1130P Severe oral mucositis (SOM) mitigation by genetically modified lactococcus lactis bacteria (LLB) producing human trefoil factor 1 (hTFF1; AG013) in patients being treated with concomitant chemoradiation (CRT) for oral and oropharyngeal cancers (OCOPC). Annals of Oncology. 2019;30(Supplement_5).
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622610
Embedded videos